Search Result

Results for "

shorter-acting

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Adenosine Receptor (1) Adrenergic Receptor (19) Antibiotic (8) Autophagy (2) Bacterial (8) Calcium Channel (8) CaSR (2) COMT (1) Dipeptidyl Peptidase (3) ERK (3) Estrogen Receptor/ERR (2) GABA Receptor (3) Histamine Receptor (3) Isotope-Labeled Compounds (6) LPL Receptor (2) mAChR (2) Monoamine Oxidase (1) nAChR (2) Opioid Receptor (5) Potassium Channel (3) Serotonin Transporter (2) Vasopressin Receptor (3) VD/VDR (1)
By Research Areas:	Cancer (8) Cardiovascular Disease (16) Endocrinology (14) Infection (10) Inflammation/Immunology (16) Metabolic Disease (5) Neurological Disease (22)

By Targets:

Adenosine Receptor (1)

Adrenergic Receptor (19)

Antibiotic (8)

Autophagy (2)

Bacterial (8)

Calcium Channel (8)

CaSR (2)

COMT (1)

Dipeptidyl Peptidase (3)

ERK (3)

Estrogen Receptor/ERR (2)

GABA Receptor (3)

Histamine Receptor (3)

Isotope-Labeled Compounds (6)

LPL Receptor (2)

mAChR (2)

Monoamine Oxidase (1)

nAChR (2)

Opioid Receptor (5)

Potassium Channel (3)

Serotonin Transporter (2)

Vasopressin Receptor (3)

VD/VDR (1)

By Research Areas:

Cancer (8)

Cardiovascular Disease (16)

Endocrinology (14)

Infection (10)

Inflammation/Immunology (16)

Metabolic Disease (5)

Neurological Disease (22)

Inhibitors & Agonists

Peptides

Natural
Products

Isotope-Labeled Compounds

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-B1830

Estradiol enanthate	Estrogen Receptor/ERR	Endocrinology
Estradiol enanthate is a shorter-acting estrogen. The combination of Estradiol enanthate and dihydroxyprogesterone acetophenide can be used as a monthly injectable contraceptive .

HY-B0507A

Sulfathiazole sodium 3 Publications Verification	Bacterial Antibiotic	Infection
Sulfathiazole sodium is an organosulfur compound that has been used as a short-acting sulfa drug.

HY-B0507

Sulfathiazole 3 Publications Verification	Bacterial Antibiotic	Infection
Sulfathiazole, an organosulfur compound, is used as a short-acting sulfonamide antibiotic .

HY-B1288A

Oxybuprocaine Benoxinate; Novesinol; Oxybucaine	Others	Inflammation/Immunology
Oxybuprocaine is a short-acting ester-type local anesthetic agent used in ophthalmology and otolaryngology .

HY-B1510

Acrivastine BW825C	Histamine Receptor	Inflammation/Immunology Endocrinology
Acrivastine (BW825C) is a short acting histamine 1 receptor antagonist for the treatment of allergic rhinitis.

HY-B0436

Salbutamol hemisulfate 4 Publications Verification Albuterol hemisulfate; AH-3365 hemisulfate	Adrenergic Receptor Autophagy	Inflammation/Immunology Endocrinology Cancer
Salbutamol Hemisulfate (Albuterol hemisulfate) is a short-acting beta2-adrenoceptor agonist.

HY-17436

Clevidipine	Calcium Channel	Cardiovascular Disease Cancer
Clevidipine is a short-acting dihydropyridine calcium channel antagonist (IC50= 7.1 nM, V(H) = -40 mV ).

HY-B1830R

Estradiol enanthate (Standard)	Estrogen Receptor/ERR	Endocrinology
Estradiol enanthate (Standard) is the analytical standard of Estradiol enanthate. This product is intended for research and analytical applications. Estradiol enanthate is a shorter-acting estrogen. The combination of Estradiol enanthate and dihydroxyprogesterone acetophenide can be used as a monthly injectable contraceptive .

HY-132280R

Tirilazad (Standard)	Antibiotic	Infection Neurological Disease
Estradiol enanthate (Standard) is the analytical standard of Estradiol enanthate. This product is intended for research and analytical applications. Estradiol enanthate is a shorter-acting estrogen. The combination of Estradiol enanthate and dihydroxyprogesterone acetophenide can be used as a monthly injectable contraceptive .

HY-B1510S

Acrivastine D7 BW825C d₇	Histamine Receptor	Inflammation/Immunology Endocrinology
Acrivastine-d₇ is a deuterium labeled Acrivastine. Acrivastine is a short acting histamine 1 receptor antagonist.

HY-17457

Levalbuterol tartrate Levosalbutamol tartrate	Adrenergic Receptor	Neurological Disease Endocrinology
Levosalbutamol tartrate(levalbuterol) is the R-enantiomer of the short-acting β2-adrenergic receptor agonist salbutamol.

HY-15105A

SB-423562 hydrochloride	CaSR	Inflammation/Immunology
SB-423562 hydrochloride is a short-acting calcium-sensing receptor (CaR) antagonist. SB-423562 hydrochloride has the potential for osteoporosis research.

HY-B1481B

Isoetharine hydrochloride Isoetarine hydrochloride	Adrenergic Receptor	Infection
Isoetharine hydrochloride is selective, short-acting and orally active β-agonist which is widely used as a bronchodilator in the research of inhalation research .

HY-B0304AS

Dapoxetine-d7 hydrochloride LY-210448-d₇ hydrochloride	Serotonin Transporter	Neurological Disease
Dapoxetine-d₇ (hydrochloride) is the deuterium labeled Dapoxetine hydrochloride. Dapoxetine hydrochloride is a short-acting selective serotonin reuptake inhibitor (SSRI)[1].

HY-B0507S

Sulfathiazole-d4	Isotope-Labeled Compounds Bacterial	Infection
Sulfathiazole-d₄ is a deuterium labeled Sulfathiazole. Sulfathiazole, an organosulfur compound, is used as a short-acting sulfonamide antibiotic[1].

HY-15105

SB-423562	CaSR	Inflammation/Immunology
SB-423562 is a short-acting calcium-sensing receptor (CaR) antagonist. SB-423562 has the potential for osteoporosis research.

HY-B1784

Sulfisomidin Sulfaisodimidine	Bacterial Antibiotic	Infection
Sulfisomidin (Sulfaisodimidine) is an orally active short-acting sulfonamide antibacterial. Sulfisomidin can be used for the research of lower urinary tract infections .

HY-16472

Sulfacytine	Antibiotic Bacterial	Infection
Sulfacytine is a short-acting sulfonamide antibiotic. Sulfacytine is active against bacteria and is an effective agent for the research of acute uncomplicated urinary tract infections .

HY-B0507R

Sulfathiazole (Standard)	Bacterial Antibiotic	Infection
Sulfathiazole (Standard) is the analytical standard of Sulfathiazole. This product is intended for research and analytical applications. Sulfathiazole, an organosulfur compound, is used as a short-acting sulfonamide antibiotic .

HY-B0304AS1

Dapoxetine-d6 hydrochloride LY-210448-d₆ hydrochloride	Isotope-Labeled Compounds Serotonin Transporter	Neurological Disease
Dapoxetine-d6 (LY-210448-d6) hydrochloride is the deuterium labeled Dapoxetine hydrochloride. Dapoxetine hydrochloride is a short-acting selective serotonin reuptake inhibitor (SSRI)

HY-B1510R

Acrivastine (Standard)	Histamine Receptor	Inflammation/Immunology Endocrinology
Acrivastine (Standard) is the analytical standard of Acrivastine. This product is intended for research and analytical applications. Acrivastine (BW825C) is a short acting histamine 1 receptor antagonist for the treatment of allergic rhinitis.

HY-17436R

Clevidipine (Standard)	Calcium Channel	Cardiovascular Disease Cancer
Clevidipine (Standard) is the analytical standard of Clevidipine. This product is intended for research and analytical applications. Clevidipine is a short-acting dihydropyridine calcium channel antagonist (IC50= 7.1 nM, V(H) = -40 mV ).

HY-100845

Salvinorin A Divinorin A	Opioid Receptor	Cardiovascular Disease
Salvinorin A is a potent, unique and short-acting high efficacy kappa-opioid receptor (KOPr) agonist with K_i value of 4.3 nm. Salvinorin A is a non-nitrogenous neoclerodane isolated from Salvia divinorum.

HY-135230

LY2444296 FP3FBZ	Opioid Receptor	Neurological Disease
LY2444296 is an orally bioavailable, high-affinity and selective short-acting kappa opioid receptor (KOPR) antagonist, with a K_i value of ∼1 nM. LY2444296 exhibits anti-anxiety like effects .

HY-B0436R

Salbutamol (hemisulfate) (Standard)	Adrenergic Receptor Autophagy	Inflammation/Immunology Endocrinology Cancer
Salbutamol (hemisulfate) (Standard) is the analytical standard of Salbutamol (hemisulfate). This product is intended for research and analytical applications. Salbutamol Hemisulfate (Albuterol hemisulfate) is a short-acting beta2-adrenoceptor agonist.

HY-116457

Propanidid Sombrevin; Fabantol	GABA Receptor	Cardiovascular Disease Neurological Disease
Propanidid (Sombrevin; Fabantol) is a γ-aminobutyric acid type A (GABA_A) receptor agonist and a short-acting non-barbiturate general agent that can suppress or relieve pain. Propanidid can decrease the arterial pressure .

HY-B1784R

Sulfisomidin (Standard)	Bacterial Antibiotic	Infection
Sulfisomidin (Standard) is the analytical standard of Sulfisomidin. This product is intended for research and analytical applications. Sulfisomidin (Sulfaisodimidine) is an orally active short-acting sulfonamide antibacterial. Sulfisomidin can be used for the research of lower urinary tract infections .

HY-106450

Binodenoson MRE-0470; WRC 0470	Adenosine Receptor	Cardiovascular Disease
Binodenoson (MRE-0470) is a potent and selective A2A adenosine receptor agonist (K_D=270 nM). Binodenoson is being developed as a short-acting coronary vasodilator as an adjunct to radiotracers for use in myocardial stress imaging .

HY-B1675A

Levalbuterol hydrochloride (R)-Albuterol hydrochloride; (R)-Salbutamol hydrochloride; Levosalbutamol hydrochloride	Adrenergic Receptor	Inflammation/Immunology
Levalbuterol ((R)-Albuterol) hydrochloride is a short-acting β2-adrenergic receptor agonist and the active (R)-enantiomer of Salbutamol. Levalbuterol hydrochloride is a more potent bronchodilator than Salbutamol and has the potential for the treatment of COPD .

HY-137920

Salvinorin A propionate	Opioid Receptor	Cardiovascular Disease
Salvinorin A (Divinorin A) propionate is a potent, unique and short-acting high efficacy kappa-opioid receptor (KOPr) agonist with K_i value of 4.3 nm. Salvinorin A propionate is a non-nitrogenous neoclerodane isolated from Salvia divinorum .

HY-17436S1

Clevidipine-d7	Isotope-Labeled Compounds Calcium Channel	Cardiovascular Disease
Clevidipine-d₇ is the deuterium labeled Clevidipine. Clevidipine is a short-acting dihydropyridine calcium channel antagonist (IC50= 7.1 nM, V(H) = -40 mV ) under development for treatment of perioperative hypertension[1][2].

HY-B1037S

Salbutamol-d3 Albuterol-d₃; AH-3365-d₃	Adrenergic Receptor	Neurological Disease Endocrinology
Salbutamol-d₃ is the deuterium labeled Salbutamol. Salbutamol is a short-acting β2-adrenergic receptor agonist used for the relief of bronchospasm in conditions such as asthma and chronic obstructive pulmonary disease (COPD).

HY-W719074

Sulfisomidin-d4 Sulfaisodimidine-d₄	Isotope-Labeled Compounds Antibiotic Bacterial	Infection
Sulfisomidin-d₄ (Sulfaisodimidine-d₄) is deuterium labeled Sulfisomidin. Sulfisomidin (Sulfaisodimidine) is an orally active short-acting sulfonamide antibacterial. Sulfisomidin can be used for the research of lower urinary tract infections .

HY-B1675

Levalbuterol (R)-Albuterol; (R)-Salbutamol; Levosalbutamol	Adrenergic Receptor	Inflammation/Immunology
Levalbuterol ((R)-Albuterol; (R)-Salbutamol) is a short-acting β2-adrenergic receptor agonist and the active (R)-enantiomer of Salbutamol. Levalbuterol is a more potent bronchodilator than Salbutamol and has the potential for the treatment of COPD .

HY-B1037S2

Salbutamol-d9 Albuterol-d₉; AH-3365-d₉	Isotope-Labeled Compounds Adrenergic Receptor	Neurological Disease Endocrinology
Salbutamol-d₉ is the deuterium labeled Salbutamol. Salbutamol is a short-acting β2-adrenergic receptor agonist used for the relief of bronchospasm in conditions such as asthma and chronic obstructive pulmonary disease (COPD).

HY-15708

LY2795050	Opioid Receptor	Neurological Disease
LY2795050 is a short-acting selective κκ-opioid receptor (KOR) antagonist. LY2795050 has high affinity for the KOR with K_i value of 0.72 nM. LY2795050 can be used for the research of central nervous system dysfunction .

HY-B1700A

Mivacurium dichloride	nAChR	Neurological Disease
Mivacurium dichloride is a benzylisoquinoline derivative and is a short-acting non-depolarizing neuromuscular blocking agent and skeletal muscle relaxant. Mivacurium dichloride couples with the nAChR to reduce or inhibit the depolarizing effect of acetylcholine on the terminal disc of the muscle cell .

HY-129451

HIE-124	GABA Receptor	Others
HIE-124 is a potent ultra-short acting hypnotic that exhibits a rapid onset of action and a shorter duration of action with no acute tolerance or noticeable side effects. HIE-124 is promising for research of preanesthetic medication and anesthesia inducer .

HY-17436S4

Clevidipine-15N,d10	Calcium Channel Isotope-Labeled Compounds	Cardiovascular Disease Cancer
Clevidipine- ¹⁵N,d₁₀ is ¹⁵N and deuterated labeled Clevidipine (HY-17436). Clevidipine is a short-acting dihydropyridine calcium channel antagonist (IC50= 7.1 nM, V(H)=-40 mV ).

HY-127128

Flestolol sulfate ACC-9089 sulfate	Adrenergic Receptor	Neurological Disease
Flestolol (ACC-9089) sulfate is a competitive, ultra-short-acting beta-adrenergic blocking agent. Flestolol sulfate shows a half-life of approximately 6.5 minutes. Flestolol sulfate has the potential for the research of chest pain .

HY-B1037S3

Salbutamol-d9 acetate Albuterol-d₉ acetate; AH-3365-d₉ acetate	Adrenergic Receptor	Endocrinology
Salbutamol-d₉ (acetate) is the deuterium labeled Salbutamol[1]. Salbutamol is a short-acting β2-adrenergic receptor agonist used for the relief of bronchospasm in conditions such as asthma and chronic obstructive pulmonary disease (COPD).

HY-106842

Nitecapone OR-462	COMT	Neurological Disease Inflammation/Immunology
Nitecapone (OR-462) is an orally active and short-acting catechol-O-methyltransferase (COMT) inhibitor with gastroprotective and antioxidant properties. Nitecapone (OR-462) scavenges reactive oxygen and nitric radicals and prevents lipid peroxidation .

HY-B0321R

Tropicamide (Standard) Ro 1-7683 (Standard)	mAChR	Neurological Disease
Tropicamide (Standard) is the analytical standard of Tropicamide. This product is intended for research and analytical applications. Tropicamide (Ro 1-7683) is a selective M4 muscarinic acetylcholine receptor antagonist. Tropicamide produces short acting mydriasis (dilation of the pupil) and cycloplegia when applied as eye drops .

HY-100607A

Landiolol hydrochloride ONO1101 hydrochloride	Adrenergic Receptor	Cardiovascular Disease Endocrinology
Landiolol hydrochloride (ONO1101 hydrochloride) is a highly beta1 selective ultra-short acting beta-blocker (β1/β2 selectivity = 255:1, a half-life of 4 min)， acts as an adrenoceptor antagonist .

HY-B0321S

Tropicamide-d3 Ro 1-7683-d₃	mAChR	Neurological Disease
Tropicamide-d₃ is the deuterium labeled Tropicamide[1]. Tropicamide (Ro 1-7683) is a selective M4 muscarinic acetylcholine receptor antagonist. Tropicamide produces short acting mydriasis (dilation of the pupil) and cycloplegia when applied as eye drops[2][3].

HY-100607

Landiolol ONO1101	Adrenergic Receptor	Cardiovascular Disease Endocrinology
Landiolol hydrochloride (ONO1101 hydrochloride) is a highly beta1 selective ultra-short acting beta-blocker (β1/β2 selectivity = 255:1, a half-life of 4 min), acts as an adrenoceptor antagonist .

HY-B0422

Nateglinide A4166; Senaglinide	Potassium Channel Dipeptidyl Peptidase	Metabolic Disease
Nateglinide, a D-phenylalanine derivative, is an orally active and short-acting insulinotropic agent and a DPP IV inhibitor. Nateglinide inhibits ATP-sensitive K ⁺ channels in pancreatic β-cells. Nateglinide is used for the treatment of type 2 (non-insulin-dependent) diabetes mellitus .

HY-17611A1

Etripamil hydrochloride MSP-2017 hydrochloride; (-)-MSP-2017 hydrochloride	Calcium Channel	Neurological Disease
Etripamil (MSP-2017) hydrochloride is a short-acting, L-type calcium channel antagonist that can be used in the study of paroxysmal supraventricular tachycardia (PSVT). Etripamil hydrochloride inhibits calcium influx through slow calcium channels, thereby slowing atrioventricular node conduction and prolonging the atrioventricular node refractory period.

HY-P1810

c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-Agm	Vasopressin Receptor	Neurological Disease
c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-Agm is a is a potent, selective and short-acting peptidic V₂ receptor (V₂R) agonist with EC₅₀s of 0.25 and 0.05 nM for hV₂R and rV₂R, respectively .

HY-17436S3

(R)-Clevidipine-13C,d3	Calcium Channel	Cardiovascular Disease
(R)-Clevidipine- ¹³C,d₃ is the deuterium and ¹³C labeled Clevidipine[1]. Clevidipine is a short-acting dihydropyridine calcium channel antagonist (IC50= 7.1 nM, V(H) = -40 mV ) under development for treatment of perioperative hypertension[2].

Cat. No.	Product Name	Target	Research Area

HY-P1809A

Velmupressin acetate c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-d-Arg-NEt2 acetate	Vasopressin Receptor	Metabolic Disease
Velmupressin (c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-d-Arg-NEt2) acetate is a potent, selective and short-acting peptidic V₂ receptor (V₂R) agonist with EC₅₀s of 0.07 and 0.02 nM for hV₂R and rV₂R, respectively .